[Plutonium-329 metabolic characteristics during the separate and combined administration of an iron preparation and DTPA].
D000818:Animals; D005290:Ferric Compounds / Q000008:administration & dosage* / Q000378:metabolism; D007501:Iron / Q000008:administration & dosage*; D008297:Male; D004369:Pentetic Acid / Q000008:administration & dosage* / Q000378:metabolism; D011005:Plutonium / Q000378:metabolism*; D011837:Radiation-Protective Agents / Q000378:metabolism; D051381:Rats; D013997:Time Factors; D014018:Tissue Distribution
D005290:Ferric Compounds; D011837:Radiation-Protective Agents; D011005:Plutonium; C025314:ferric citrate; D004369:Pentetic Acid; D007501:Iron
Osobennosti metabolizma plutoniia-239 pri razdel'nom i kombinirovannom vvedenii preparata zheleza i DTPA.